Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,887 | -8,758 | -1,790 | -7,126 | -5,707 |
| Other Working Capital | 4,817 | 4,977 | -72 | -10 | 38 |
| Other Operating Activity | 1,152 | 673 | 310 | 1,374 | 1,055 |
| Operating Cash Flow | $-4,919 | $-3,108 | $-1,552 | $-5,762 | $-4,614 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 104 | N/A | N/A | N/A |
| Debt Issued | 2,104 | 2,000 | N/A | N/A | N/A |
| Common Stock Issued | 3,431 | 3,330 | 21 | 6,107 | 5,800 |
| Financing Cash Flow | $5,535 | $5,435 | $21 | $6,107 | $5,800 |
| Beginning Cash Position | 5,664 | 5,664 | 5,664 | 5,319 | 5,319 |
| End Cash Position | 6,281 | 7,990 | 4,133 | 5,664 | 6,505 |
| Net Cash Flow | $617 | $2,327 | $-1,531 | $345 | $1,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,919 | -3,108 | -1,552 | -5,762 | -4,614 |
| Free Cash Flow | -4,919 | -3,108 | -1,552 | -5,762 | -4,614 |